Additionally, it could decrease the release of IL-1β and IL-18 inflammatory cytokines while mitigating lung tissue inflammation and consequently improving lung function and relieving dyspnea symptoms among patients with COPD. The gene discussed is IL1B; the disease is chronic obstructive pulmonary disease.